Cindy Boer

62 | Chapter 1.2 155. Peng H, Lu S‐L, Bai Y, Fang X, Huang H, Zhuang X‐Q. MiR‐133a inhibits fracture healing via targeting RUNX2/BMP2. Eur Rev Med Pharmacol Sci. 2018; 22(9): 2519– 26. 156. Zhang D, Cao X, Li J, Zhao G. MiR‐210 inhibits NF‐κB signaling pathway by targeting DR6 in osteo- arthritis. Sci Rep. 2015; 5(1): 12775. 157. Lolli A, Narcisi R, Lambertini E, et al. Silencing of antichondrogenic microRNA‐221 in human mes- enchymal stem cells promotes cartilage repair in vivo. Stem Cells. 2016; 34(7): 1801– 11. 158. Qureshi AT, Doyle A, Chen C, et al. Photoactivated miR‐148b‐nanoparticle conjugates improve clo- sure of critical size mouse calvarial defects. Acta Biomater. 2015; 12: 166– 73. 159. Eskildsen T, Taipaleenmaki H, Stenvang J, et al. MicroRNA‐138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci. 2011; 108(15): 6139– 44. 160. Song J, Kim D, Chun C‐H, Jin E‐J. miR‐370 and miR‐373 regulate the pathogenesis of osteoarthritis by modulating one‐carbon metabolism via SHMT‐2 and MECP‐2, respectively. Aging Cell. 2015; 14(5): 826– 37. 161. Chen X, Gu S, Chen B‐F, et al. Nanoparticle delivery of stable miR‐199a‐5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway. Biomaterials. 2015; 53: 239– 50. 162. Fukuda T, Ochi H, Sunamura S, et al. MicroRNA‐145 regulates osteoblastic differentiation by target- ing the transcription factor Cbfb. FEBS Lett. 2015; 589(21): 3302– 8. 163. Wang G‐L, Wu Y‐B, Liu J‐T, Li C‐Y. Upregulation of miR‐98 inhibits apoptosis in cartilage cells in os- teoarthritis. Genet Test Mol Biomarkers. 2016; 20(11): 645– 53. 164. Li H, Li T, Fan J, et al. miR‐216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c‐Cbl‐mediated PI3K/AKT pathway. Cell Death Differ. 2015; 22(12): 1935– 45. 165. Xie Q, Wei W, Ruan J, et al. Effects of miR‐146a on the osteogenesis of adipose‐derived mesenchy- mal stem cells and bone regeneration. Sci Rep. 2017; 7(1): 42840. 166. Zhang X, Li Y, Chen YE, Chen J, Ma PX. Cell‐free 3D scaffold with two‐stage delivery of miRNA‐26a to regenerate critical‐sized bone defects. Nat Commun. 2016; 7: 10376. 167. Cheng P, Chen C, He H‐B, et al. miR‐148a regulates osteoclastogenesis by targeting V‐maf muscu- loaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res. 2013; 28(5): 1180– 90. 168. Lee WY, Li N, Lin S, Wang B, Lan HY, Li G. miRNA‐29b improves bone healing in mouse fracture model. Mol Cell Endocrinol. 2016; 430: 97– 107. 169. Arfat Y, Basra MAR, Shahzad M, Majeed K, Mahmood N, Munir H. miR‐208a‐3p suppresses osteo- blast differentiation and inhibits bone formation by targeting ACVR1. Mol Ther Nucleic Acids. 2018; 11: 323– 36. 170. Hu C‐H, Sui B‐D, Du F‐Y, et al. miR‐21 deficiency inhibits osteoclast function and prevents bone loss in mice. Sci Rep. 2017; 7(1): 43191. 171. Krzeszinski JY, Wei W, Huynh H, et al. miR‐34a blocks osteoporosis and bone metastasis by inhibit- ing osteoclastogenesis and Tgif2. Nature. 2014; 512: 431– 5. 172. Sun Y, Xu J, Xu L, et al. MiR‐503 promotes bone formation in distraction osteogenesis through sup- pressing Smurf1 expression. Sci Rep. 2017; 7(1): 409. 173. Deng L, Hu G, Jin L, Wang C, Niu H. Involvement of microRNA‐23b in TNF‐α‐reduced BMSC osteo- genic differentiation via targeting runx2. J Bone Miner Metab. 2018; 36(6): 648– 60. 174. Chen S, Zheng Y, Zhang S, Jia L, Zhou Y. Promotion effects of miR‐375 on the osteogenic differen- tiation of human adipose‐derived mesenchymal stem cells. Stem Cell Rep. 2017; 8(3): 773– 86. 175. Su X, Liao L, Shuai Y, et al. MiR‐26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis. 2015; 6(8): e1851. 176. Wei J, Shi Y, Zheng L, et al. miR‐34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol. 2012; 197(4): 509– 21.